Philip Morris Intl. expands into cannabis via Avicanna partnership, focusing on medical research and innovation: How this ...

Philip Morris International Inc. (PM) stock saw a modest uptick, ending the day at $121.59 which represents a slight increase of $1.79 or 1.49% from the prior close of $119.8. The stock opened at $119 ...

Global leaders at the World Economic Forum in Davos have voiced urgent calls for Europe to rethink its economic and ...

Assenagon Asset Management S.A. lessened its holdings in shares of Philip Morris International Inc. (NYSE:PM – Free Report) ...

In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Moody National Bank Trust Division grew its stake in shares of Philip Morris International Inc. (NYSE:PM – Free Report) by ...

Tobacco stocks gained slightly on Thursday after the FDA has authorized the marketing of 20 Zyn nicotine pouch products ...

Philip Morris International Inc. closed $16.60 below its 52-week high ($134.15), which the company reached on October 31st.

Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International's Zyn ...

Philip Morris International Inc. (PM) stock saw a modest uptick, ending the day at $121.86 which represents a slight increase of $0.46 or 0.38% from the prior close of $121.4. The stock opened at $120 ...

Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40, late Thursday ...